Quantum Leap Healthcare Collaborative
Smita Asare has a diverse work experience in various healthcare and research settings. Smita started their career as a Research Analyst at the University of Missouri Health Care in 1998. Smita then worked as a Programmer Analyst II at the Immune Tolerance Network in 2004. Later, they joined the George Washington University's Milken Institute School of Public Health, where they served as a Senior Research Assistant and a Research Associate at the Type 1 Diabetes TrialNet Coordinating Center. In 2008, they joined UCSF Medical Center as the Team Leader - Tolerance Research Project Manager and later became the Mechanistic Operations Manager in the Biomarker & Discovery Research division of the Immune Tolerance Network. From 2013 to 2015, they worked as a Data Analyst at the Massachusetts General Hospital in the Bioinformatics department of the Immune Tolerance Network. Currently, they hold the position of Executive Director for I-SPY Trials Operations at Quantum Leap Healthcare Collaborative, starting from 2016.
Smita Asare completed their Bachelor of Science degree in Molecular & Integrative Physiology from the University of Illinois Urbana-Champaign in the years 1993 to 1997. Later on, they pursued another Bachelor of Science degree in Computer Science from the University of Missouri College of Engineering between 2000 and 2003.
This person is not in any teams
Quantum Leap Healthcare Collaborative
A 501C(3) charitable organization, Quantum Leap was established in 2005 as a collaboration between medical researchers at University of California, San Francisco and Silicon Valley entrepreneurs. Our mission is to integrate high-impact research with clinical processes and systems technology, resulting in improved data management and information systems, greater access to clinical trial matching and sponsorship, and greater benefit to providers, patients and researchers. Our goal is to improve and save lives. The founders of Quantum Leap recognize that good ideas and research projects in a University setting were often “orphaned” at the end of a research project. These efforts were frequently left with no funds or organizational structure to adequately engage clinical providers and ultimately benefit patient care. In addition, the intellectual property often created as part of these research endeavors remain untapped and undeveloped. Modeled after Silicon Valley’s entrepreneurial culture with an added social value objective, our social-entrepreneurial model embodies: + Identifying clinical and research efforts with a potential for high impact + Providing financial and managerial assistance + Forming organizations and management teams to grow proven ideas into products + Securing funding in stages as efforts mature + Creating strategic partnerships committed to developing high-value healthcare services and products We support the development and implementation of innovative ways to deliver better, less costly healthcare. We are committed to establishing unique collaborations across the medical, technology and bioscience industries: all necessary components to accelerate healthcare research into the marketplace. Our efforts focus on quality-of-care and quality-of-life issues, and to create initiatives that foster excellent clinical practices using quality improvement disciplines with a strong patient-centric focus.